WeVote
Log In

Bill

Bill

SB 523

Requiring candidates for municipal offices to file campaign financial statements and financial reports

2025 Regular Session Introduced by Jack Woodrum

SB 523 provides up to 4 hours of paid cancer screening leave per 12 months for all state employees, with SBM rulemaking by July 1, 2025 and agency HR/payroll updates.

To Government Organization
#elections
0
WeVote Research Nonpartisan
Bill Summary · SB 523

Summary — SB 523: State Employees — Cancer Screening — Paid Leave

Status: Hearing scheduled 3/25 at 1:00 p.m.
Introduced: December 3, 2024
Sponsor: Senator Charles (designated cross‑file HB 914 — Delegates Vogel & Wolek)
Effective date (as drafted): July 1, 2025

Purpose / Intent

To ensure State employees have a specific, paid leave entitlement to obtain cancer screening, with the goal of supporting early detection and employee health while establishing uniform statewide procedures and regulatory oversight.

Key provisions

  • Entitlement: Authorizes an employee to use up to 4 hours of paid cancer screening leave in any 12‑month period.
  • Covered employees: Applies to all State employees, explicitly including temporary and part‑time employees, across executive, judicial, and legislative branches (and units with independent personnel systems).
  • Approval and procedures: Use of the leave is subject to approval by the employee’s appointing authority.
  • Rulemaking: The Secretary of Budget and Management is required to adopt regulations governing cancer screening leave, including conditions and procedures for requesting and approving the leave.
  • Implementation date: Provisions take effect July 1, 2025 (per the bill text).

Who is affected

  • Directly: State government employees (full‑time, part‑time, and temporary) who need time for cancer screening.
  • Indirectly: State agencies (human resources and payroll) — responsible for processing requests, implementing procedures, training staff, and making any necessary personnel system configuration changes.

Fiscal and operational impact

  • Fiscal: The Department of Budget and Management estimates a likely minimal increase in State expenditures beginning in FY 2026, primarily from overtime or other coverage costs when employees are away for screening. State revenues are not affected.
  • Utilization note: DBM observed roughly 20,000 employees used State health insurance for cancer screening in the prior year — indicating substantial potential take‑up — but most agencies already budget regular salaries and may not hire temporary replacements.
  • Administrative: Agencies will need to:
    • Train HR personnel on the new leave type.
    • Update leave tracking/payroll systems and policies.
    • The Secretary’s regulations may further define eligibility/approval conditions, which could moderate costs.
  • Potential offsets: Earlier detection could reduce State health insurance costs over time (State is largely self‑insured), but any savings are speculative and not quantified in the fiscal note.

Procedural / timeline notes

  • Rulemaking: Secretary of Budget and Management must promulgate implementing regulations prior to or concurrent with effective date.
  • Legislative process: Cross‑filed as HB 914; fiscal note prepared; committee hearing(s) are part of the record.

Tradeoffs / considerations

  • Small, time‑limited paid leave (4 hours/year) balances access to preventive care with limited operational disruption, but agencies may experience localized coverage burdens depending on staffing patterns.
  • The regulatory phase will determine practical access (notice, documentation, scheduling windows) and thus affect both utilization and fiscal consequences.

If you want, I can:
- Draft a one‑page talking points memo for agency HR directors on implementing the leave; or
- Extract and summarize the specific regulatory questions the Secretary will likely need to resolve.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.